Baxano Surgical Inc  

(Public, OTCMKTS:BAXSQ)   Watch this stock  
Find more results for NASDAQ:BAXS
0.00000 (0.00%)
- Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 149,180.00
P/E     -
Div/yield     -
EPS -0.68
Shares 49.73M
Beta     -
Inst. own 43%

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -126.01% -172.35%
Operating margin -167.40% -171.15%
EBITD margin - -138.00%
Return on average assets -56.63% -78.84%
Return on average equity -117.23% -126.62%
Employees 139 -
CDP Score - -


110 Horizon Dr Ste 230
RALEIGH, NC 27615-4927
United States - Map
+1-919-8000020 (Phone)
+1-800-2535177 (Fax)

Website links


Baxano Surgical, Inc., formerly Baxano Inc. is a medical device company. The Company is focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. The Company markets the AxiaLIF pre-sacral access and interbody fusion system for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system, the iO-Flex set of flexible instruments used by surgeons during spinal decompression procedures, and the iO-Tome instrument for rapid and precise removal of bone, specifically the facet joints, a technique which is commonly performed in spinal fusion procedures. The Company’s other products include: Vectre facet screw system, Bi-Ostetic bone void filler, bowel retractors, discectomy tools, and a bone graft harvesting system that can be used to extract bone graft from the patient’s hip for use in fusion procedures.